The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]
PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]
Sorry, this entry is only available in Italian. PharmaNutra lancia una nuova campagna TV, radio e digital dedicata al complemento […]
Innovative, versatile and easy to apply – available in pharmacies from today – it’s an expansion to the patented Cetylated […]
PharmaNutra S.p.A. informs that the Board of Directors has examined and approved the consolidated interim report on 30th June 2020, […]
The PharmaNutra Group further strengthens its presence outside Europe thanks to a new trade agreement with the Bolivian pharmaceutical company […]
Businesses and universities unite at the Sinergie-SIMA 2020 Conference in an effort to promote change and discuss present and future […]
The IQVIA figures for the first half of 2020 confirm the stability of PharmaNutra leadership in the nutritional supplements sector. […]
After three years since being listed on the AIM Italia Market, PharmaNutra takes stock of the situation: from the industrial […]
PharmaNutra also climbs the annual IQVIA ranking in number of products sold, coming twelfth out of more than 1700 Italian […]
Market Insight continues its in-depth study of PharmaNutra S.p.A. through interviews with Chairman and CEO, Roberto Lacorte, and Managing Director, […]
Great investor interest in the Company’s strategies during the virtual edition of the conference organised today by the Italian Stock […]
